Switch to:
More From Other Websites
Activists want 'imminent retirement' of Ariad CEO Feb 20 2015
Merck Snags Cubist, Fighter of Superbugs, for $9.5B Dec 08 2014
Health care M&A leads global deal surge Nov 23 2014
Biotech targets: Cramer's quality candidates Sep 11 2014
UPDATE: Deutsche Bank Initiates Coverage On Merck Aug 27 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Bradlewski
ReplyBradlewski - 10 months ago
Merck is buying it for $24.5/share.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK